BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11313471)

  • 1. DR3 regulates negative selection during thymocyte development.
    Wang EC; Thern A; Denzel A; Kitson J; Farrow SN; Owen MJ
    Mol Cell Biol; 2001 May; 21(10):3451-61. PubMed ID: 11313471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection.
    Page DM; Roberts EM; Peschon JJ; Hedrick SM
    J Immunol; 1998 Jan; 160(1):120-33. PubMed ID: 9551964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor receptor family members in the immune system.
    Gravestein LA; Borst J
    Semin Immunol; 1998 Dec; 10(6):423-34. PubMed ID: 9826575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of CD30 on T lymphocytes.
    Tarkowski M
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):217-21. PubMed ID: 10483869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI).
    Su WB; Chang YH; Lin WW; Hsieh SL
    Exp Cell Res; 2006 Feb; 312(3):266-77. PubMed ID: 16324699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.
    Newton K; Harris AW; Strasser A
    EMBO J; 2000 Mar; 19(5):931-41. PubMed ID: 10698935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the protective role of death receptor 3 (DR3) in renal injury using an organ culture model.
    Al-Lamki RS
    Methods Mol Biol; 2014; 1155():69-79. PubMed ID: 24788174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for c-myc in the regulation of thymocyte differentiation and possibly positive selection.
    Broussard-Diehl C; Bauer SR; Scheuermann RH
    J Immunol; 1996 May; 156(9):3141-50. PubMed ID: 8617934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 regulates thymocyte survival during development in fetal thymic organ culture.
    Ferguson BV; Ostergaard HL
    Immunobiology; 2010 Jun; 215(6):458-65. PubMed ID: 19765855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma.
    Grenet J; Valentine V; Kitson J; Li H; Farrow SN; Kidd VJ
    Genomics; 1998 May; 49(3):385-93. PubMed ID: 9615223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.
    Erickson SL; de Sauvage FJ; Kikly K; Carver-Moore K; Pitts-Meek S; Gillett N; Sheehan KC; Schreiber RD; Goeddel DV; Moore MW
    Nature; 1994 Dec; 372(6506):560-3. PubMed ID: 7990930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
    J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
    Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
    Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miz-1 is required to coordinate the expression of TCRbeta and p53 effector genes at the pre-TCR "beta-selection" checkpoint.
    Saba I; Kosan C; Vassen L; Klein-Hitpass L; Möröy T
    J Immunol; 2011 Sep; 187(6):2982-92. PubMed ID: 21841135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death.
    Zhan Y; Funda DP; Every AL; Fundova P; Purton JF; Liddicoat DR; Cole TJ; Godfrey DI; Brady JL; Mannering SI; Harrison LC; Lew AM
    Int Immunol; 2004 Sep; 16(9):1315-21. PubMed ID: 15262900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection.
    Friedrich ML; Wen BG; Bain G; Kee BL; Katayama C; Murre C; Hedrick SM; Walsh CM
    Int Immunol; 2005 Nov; 17(11):1379-90. PubMed ID: 16172133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between the T cell antigen receptor and the glucocorticoid receptor regulates thymocyte development.
    Ashwell JD; King LB; Vacchio MS
    Stem Cells; 1996 Sep; 14(5):490-500. PubMed ID: 8888490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases.
    Aggarwal S; Gollapudi S; Gupta S
    J Immunol; 1999 Feb; 162(4):2154-61. PubMed ID: 9973490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal thymocyte negative selection in TRAIL-deficient mice.
    Cretney E; Uldrich AP; Berzins SP; Strasser A; Godfrey DI; Smyth MJ
    J Exp Med; 2003 Aug; 198(3):491-6. PubMed ID: 12900523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.